| Melissa Marie Moss, | |
|
5410 N 44th St, Tacoma, WA 98407-3715 | |
| (253) 759-9544 | |
| Not Available |
| Full Name | Melissa Marie Moss |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 5410 N 44th St, Tacoma, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003185489 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Marie Moss, 5410 N 44th St, Tacoma, WA 98407-3715 Ph: (253) 759-9544 | Melissa Marie Moss, 5410 N 44th St, Tacoma, WA 98407-3715 Ph: (253) 759-9544 |
News Archive
Employers who understand the link between employee well-being and organizational performance are best positioned for success in the economic recovery, the American Psychological Association reported at its Psychologically Healthy Workplace Awards ceremony this weekend. APA recognized five organizations for their comprehensive efforts to promote employee health and well-being while enhancing organizational performance.
Valeant Pharmaceuticals announced that it has introduced Kinerase(R) Intensive Eye Cream, based on the successful formula of its Kinerase facial lotion and cream. The new eye cream contains a 25 percent higher concentration of Kinetin, the natural substance in Kinerase products that helps the skin retain moisture and reduces the appearance of fine lines and wrinkles.
"To break free of its dependence on donor money and supplies from India, Africa must develop its own pharmaceutical pipeline by creating policy frameworks that encourage a fledgling drug industry," journalist Priya Shetty argues in this SciDev.Net opinion piece.
Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.
GenSpera, Inc. announced that its patent application, entitled "Tissue Specific Prodrugs," has been issued by the United States Patent and Trademark Office as US Patent 7,767,648. The patent covers the method of use for G-202, GenSpera's lead oncology drug, which is currently in a Phase I clinical study treating cancer patients whose disease has progressed after other treatments.
› Verified 3 days ago
Kenneth E Clifton, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-4631 | |
David Andrew Ryan, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5410 N 44th St, Tacoma, WA 98407 Phone: 253-759-9544 | |
Leah Marie Bedker, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5410 N 44th St, Tacoma, WA 98407 Phone: 253-759-9544 | |
Ms. Kimberly Noel Zacher, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1201 S Proctor St, Tacoma, WA 98405 Phone: 253-396-5800 Fax: 253-759-7008 | |
Mr. James Wesley Pogue Jr., MBA Counselor Medicare: Not Enrolled in Medicare Practice Location: 610 Yakima Ave, Tacoma, WA 98405 Phone: 253-396-5237 | |
Ms. Sarah Lisa Bennett, MA, LMHC Counselor Medicare: Medicare Enrolled Practice Location: 3021 6th Ave, Tacoma, WA 98406 Phone: 253-326-2816 | |
Barbara J Cook, AA Counselor Medicare: Not Enrolled in Medicare Practice Location: 514 S 13th St, Tacoma, WA 98402 Phone: 253-396-5000 Fax: 253-383-5548 |